1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Global Drug Discovery and Development Analysis & Statistics, September 2016

Global Drug Discovery and Development Analysis & Statistics, September 2016

1-30 of about 1 400 reports

Purchase Reports From Reputable Market Research Publishers

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States, Europe, North America
Trends in Gene Therapy

Trends in Gene Therapy

  • $ 5 000
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

The number of gene therapy products in preclinical to Phase III and beyond stages of development doubled between 2012 and 2015. Additionally, three gene therapy products have received regulatory approval ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : Europe, United States
Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

  • $ 4 995
  • Industry report
  • August 2016
  • by GBI Research

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period Summary Ophthalmology is a therapy area that deals with the diagnosis, ...

  • Industries : General Medicine and Specialty Medicine, Healthcare
  • Countries : World
Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

  • $ 4 995
  • Industry report
  • August 2016
  • by GBI Research

Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment Summary Diabetes is a chronic metabolic disease ...

  • Industries : Pathology, Chronic Disease, Healthcare, Therapy
  • Countries : World
Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way

Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way

  • $ 4 995
  • Industry report
  • August 2016
  • by GBI Research

Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way Summary The respiratory therapy ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease, Pathology
  • Countries : World
Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

  • $ 4 995
  • Industry report
  • August 2016
  • by GBI Research

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 - Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth Summary Diabetes mellitus is ...

  • Industries : Therapy, Pharmaceutical
  • Countries : World, Asia
Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies

Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies

  • $ 4 995
  • Industry report
  • July 2016
  • by GBI Research

Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies Summary Osteoporosis, the most common metabolic ...

  • Industries : Therapy, Chronic Disease, Pathology, Pharmaceutical
  • Countries : World, Asia
Genome Editing Global Market - Forecast to 2022

Genome Editing Global Market - Forecast to 2022

  • $ 4 950
  • Industry report
  • September 2016
  • by IQ4I Research & Consultancy Pvt. Ltd

Ever since the establishment of the genetic basis of life, researchers have tried to manipulate genes in plants and animals to improve traits. There has been a continuous evolution of gene modification ...

  • Industries : Biotechnology
  • Countries : World
Global Lab Automation in Drug Discovery Market Segmented by type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2015 - 2020)

Global Lab Automation in Drug Discovery Market Segmented by type of Equipment, Software, Analyzers, Plate Readers and Geography Forecasts, Shares and Trends (2015 - 2020)

  • $ 4 250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Integrated robot systems are used to transport assay-microplates from station to station for sample and reagent addition, mixing, incubation, and finally readout or detection. These systems can usually ...

  • Industries : Drug Discovery and Development
  • Countries : World
Global Precision Medicine Market- Industry Assessment, Analysis and Forecast (2015 - 2020)

Global Precision Medicine Market- Industry Assessment, Analysis and Forecast (2015 - 2020)

  • $ 4 250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Precision medicine the combination of molecular biology techniques and systems biology to form an approach for developing drugs and vaccines that deliver superior outcomes to patients by using integrative ...

  • Industries : Genomics
  • Countries : World
Global Clinical Trial Support Services Market – 2015-2020

Global Clinical Trial Support Services Market – 2015-2020

  • $ 4 250
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Global Clinical Trial Support Services Market is estimated to be $ xx billion for the year 2015 to reach $ xx billion by the year 2020. The CAGR with which market is growing is anticipated to be x.x%. ...

  • Industries : Drug Discovery and Development
  • Countries : World
North America Clinical Data Analytics In Healthcare – Growth, Trends And Forecasts (2015 – 2020)

North America Clinical Data Analytics In Healthcare – Growth, Trends And Forecasts (2015 – 2020)

  • $ 3 850
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

Big Data in healthcare is overwhelming not only because of its volume but also because of the diversity of data types and the speed at which it must be managed. The totality of data related to patient ...

  • Industries : Healthcare
  • Countries : North America
N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N Sulphoglucosamine Sulphohydrolase ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World, United States
Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World
Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Mycobacterium tuberculosis ESAT 6 Protein ...

  • Industries : Biopharmaceutical
  • Countries : South Africa, World
Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Leukotriene A 4 Hydrolase (LTA 4 Hydrolase or Leukotriene A(4) Hydrolase or LTA4H or EC 3.3.2.6) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Leukotriene A 4 Hydrolase (LTA 4 Hydrolase ...

  • Industries : Pathology, Therapy, Pharmaceutical, Drug Discovery and Development
  • Countries : World, United States
Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016

Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • August 2016
  • by Global Markets Direct

Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Mycobacterium tuberculosis Protein Ag85A - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Biotechnology
  • Countries : World, South Africa
Europe Clinical Data Analytics in Healthcare Growth, Trends and Forecasts (2015 - 2020)

Europe Clinical Data Analytics in Healthcare Growth, Trends and Forecasts (2015 - 2020)

  • $ 3 500
  • Industry report
  • August 2016
  • by Mordor Intelligence LLP

The Europe clinical data analytics market was valued at $630 million in 2014 and is projected to reach $5110 million by the end of 2020, at a compound annual growth rate of 41.77% over the six year forecasted ...

  • Industries : Healthcare, Drug Discovery and Development
  • Countries : Europe
Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016

Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Tumor Necrosis Factor Receptor Superfamily Member 6 (Apo 1 Antigen or Apoptosis Mediating Surface Antigen FAS or FASLG Receptor or TNFRSF6 or CD95 or FAS) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Pathology
  • Countries : United States, World
Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H2 2016

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 or EC 3.5.1.98) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 8 (Histone Deacetylase Like 1 or HDAC8 o ...

  • Industries : Cancer, Pathology, Therapy, Drug Discovery and Development
  • Countries : China, Japan, World
Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Hepcidin (Liver Expressed Antimicrobial Peptide ...

  • Industries : Pathology
  • Countries : United States, World
Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

Caspase 3 (Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Caspase 3 (Apopain ...

  • Industries : Therapy, Pathology, Biopharmaceutical
  • Countries : United States, World
T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 ...

  • Industries : Biological Therapy, Drug Discovery and Development, Therapy, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States
TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016

  • $ 3 500
  • Company report
  • July 2016
  • by Global Markets Direct

TGF Beta Receptor Type 2 (Transforming Growth Factor Beta Receptor Type II or TGFBR2 or EC 2.7.11.30) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘TGF Beta Receptor Type 2 (Transforming ...

  • Industries : Drug Discovery and Development
  • Countries : World
TAR DNA-Binding Protein 43 (TDP-43) - Pipeline Review, H1 2016

TAR DNA-Binding Protein 43 (TDP-43) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

TAR DNA-Binding Protein 43 (TDP-43) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘TAR DNA-Binding Protein 43 (TDP-43) - Pipeline Review, H1 2016’, provides in depth analysis on TAR ...

  • Industries : Mental Health, Pathology, Therapy, Drug Discovery and Development, Pharmaceutical
  • Countries : World
Rho-Associated Protein Kinase 1 (Renal Carcinoma Antigen NY-REN-35 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 1 or p160 ROCK-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

Rho-Associated Protein Kinase 1 (Renal Carcinoma Antigen NY-REN-35 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 1 or p160 ROCK-1 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Rho-Associated Protein Kinase 1 (Renal Carcinoma Antigen NY-REN-35 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 1 or p160 ROCK-1 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets ...

  • Industries : Biopharmaceutical, Cancer, Pathology, Pharmaceutical
  • Countries : United Kingdom, World
70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘70-kDa Ribosomal Protein S6 Kinase (p70S6K or EC 2.7.11.1) - Pipeline Review, ...

  • Industries : Cancer, Biopharmaceutical, Drug Discovery and Development, Therapy, Pharmaceutical, Pathology
  • Countries : United States, World, United Kingdom
Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Aurora Kinase A (Serine ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States, China, World
Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Serine/Threonine-Protein Kinase Chk1 (Checkpoint Kinase 1 or CHK1 Checkpoint Homolog or EC 2.7.11.1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Serine/Threonine-Protein Kinase Chk1 ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : World, United States
Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • June 2016
  • by Global Markets Direct

Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis B Virus Core Antigen (HBcAg) - Pipeline Review, H1 2016’, provides in depth analysis ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.